Danaher Corporation (NYSE:DHR) is scheduled to announce its earnings results before the market opens on Thursday, October 19th. Analysts expect the company to announce earnings of $0.95 per share for the quarter. Danaher Corporation has set its Q3 guidance at $0.92-0.96 EPS and its FY17 guidance at $3.90-3.97 EPS.

Danaher Corporation (NYSE:DHR) last announced its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. During the same quarter last year, the firm posted $0.90 EPS. The company’s quarterly revenue was up 6.3% on a year-over-year basis. On average, analysts expect Danaher Corporation to post $3.95 EPS for the current fiscal year and $4.29 EPS for the next fiscal year.

Danaher Corporation (NYSE DHR) opened at 86.13 on Tuesday. The company has a market cap of $59.83 billion, a P/E ratio of 27.61 and a beta of 1.03. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.62. The stock has a 50 day moving average of $85.95 and a 200-day moving average of $84.19.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be given a dividend of $0.14 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.65%. Danaher Corporation’s payout ratio is currently 17.83%.

Several equities analysts recently weighed in on the stock. Wells Fargo & Company assumed coverage on shares of Danaher Corporation in a research report on Thursday, July 13th. They set a “market perform” rating and a $90.00 price target for the company. Goldman Sachs Group, Inc. (The) restated a “neutral” rating and set a $83.00 price target on shares of Danaher Corporation in a research report on Tuesday, September 26th. Jefferies Group LLC restated a “buy” rating and set a $95.00 price target on shares of Danaher Corporation in a research report on Friday, August 4th. BidaskClub lowered shares of Danaher Corporation from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Finally, Zacks Investment Research lowered shares of Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have given a buy rating and one has given a strong buy rating to the stock. Danaher Corporation presently has an average rating of “Buy” and a consensus target price of $92.62.

ILLEGAL ACTIVITY NOTICE: This news story was originally posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://theolympiareport.com/2017/10/17/danaher-corporation-dhr-scheduled-to-post-quarterly-earnings-on-thursday.html.

In other Danaher Corporation news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the transaction, the insider now owns 155,520 shares in the company, valued at $12,718,425.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider William King sold 7,458 shares of the stock in a transaction dated Friday, July 21st. The stock was sold at an average price of $82.97, for a total transaction of $618,790.26. Following the completion of the sale, the insider now directly owns 18,245 shares in the company, valued at $1,513,787.65. The disclosure for this sale can be found here. Insiders have sold 71,496 shares of company stock valued at $5,916,223 in the last quarter. Company insiders own 12.20% of the company’s stock.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Earnings History for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.